| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| R&D Expense | $2.6M | +558.5% |
| SG&A Expense | $2.7M | +149.3% |
| Operating Income | -$6.9M | -196.0% |
| Interest Expense | $14K | -89.4% |
| Pre-tax Income | -$7.4M | -200.2% |
| Net Income | -$7.4M | -200.2% |
| EPS (Basic) | $5.78 | +2.3% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $100K | +0.0% |
| Current Assets | $96K | +75.0% |
| Total Assets | $96K | +75.0% |
| Current Liabilities | $6.5M | +73.9% |
| Total Liabilities | $6.5M | +73.9% |
| Stockholders' Equity | -$6.4M | -73.9% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$981K | +37.4% |
| Financing Cash Flow | $1.0M | -37.0% |